Latest Cambridge Antibody Technology Stories
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced today that it has appointed Peter Brooks, Ph.D. and Sherie Morrison, Ph.D. to the company's Scientific Advisory Board. Dr.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
4-Antibody AG today announced that Dr. Richard Mason has joined the company as Chief Executive Officer and Geschaeftsfuehrer. Dr. Mason joins 4-Antibody from venture capital firm Advent Venture Partners, an investor in 4-Antibody, where he has been an Executive-in-Residence. Previously Dr.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, and Pivotal BioSciences, Inc., a privately held Los Angeles-based biotechnology company developing oncology products, today announced they have entered into an agreement in which Morphotek will access Pivotal BioSciences' LEC platform technology, developed by Dr.
KaloBios Pharmaceuticals, Inc. today announced that the company has raised $20 million in the first closing of its Series D venture financing.
OSLO, September 23 /PRNewswire/ -- Affitech AS, the Norwegian human antibody therapeutics company, today announced that it has accomplished the second milestone in its research and licensing collaboration with Roche to produce fully human recombinant antibodies against an unnamed oncology target.
US-based biopharmaceutical company Regeneron Pharmaceuticals and Columbia University have signed an agreement that will provide researchers at Columbia University Medical Center with access to Regeneron's VelocImmune technology to discover fully human monoclonal antibodies.
GAITHERSBURG, Md. and TOKYO, Sept.
ATHENS, Ga., Sept.
OSLO, Norway, September 9 /PRNewswire/ -- Affitech AS, the Norwegian antibody therapeutics company, today announced that it has appointed Dr Keith McCullagh as non-executive Chairman of its Board of Directors. The Company's previous chairman, Oyvin Broymer, will remain as a member of the Board.
- An imitative word; an onomatopoetic word.